AEZS Aeterna Zentaris Inc.
28,667
$8.37
$0.1799
(2.10%)
| Watchers | 28,667 |
| 52-Wk Low | $5.44 |
| 52-Wk High | $12.80 |
| Market Cap | $10.38M |
| Volume | 837.00 |
| 52-Wk High | $12.80 |
| 52-Wk Low | $5.44 |
Ceapro receives final court approval for merger with Aeterna ZentarisThe Fly • about 2 months ago
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Share to Feed
TORONTO and EDMONTON, Alberta, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna") and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) ( Ceapro ) are pleased to...
TORONTO and EDMONTON, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna") and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) ( Ceapro ) are pleased to announce...
Aeterna Zentaris Inc. (TSE:AEZS) has released an update. Aeterna Zentaris Inc. has received final court approval to merge with Ceapro Inc. in a str...
Ceapro Inc (TSE:CZO) has released an update. Ceapro Inc. has received final court approval for its all-stock merger with Aeterna Zentaris, with com...
- Company confirms successful completion of enrollment in the pivotal DETECT Phase 3 trial - Company ended the year with $34.0 million in cash, expected to fund operations through 2024 and into...
TORONTO and EDMONTON, Alberta, March 12, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ( Aeterna ) and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) ( Ceapro ) are pleased to...
TORONTO and EDMONTON, March 12, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ( Aeterna ) and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) ( Ceapro ) are pleased to announce...
ISS states in its Aeterna Zentaris FOR recommendation that on balance, the deal has strong strategic merit, third party solicitation was unable to generate any other actionable proposals, and...
ISS states in its Aeterna Zentaris FOR recommendation that on balance, the deal has strong strategic merit, third party solicitation was unable to generate any other actionable proposals, and...